1. Analyst View
2. Research Methodology
3. Market Overview
4. Key Market Drivers
4.1 Improved Routine Immunization
4.2 Emerging Markets
4.3 Technological Developments
4.4 Investment in Vaccine Research
5. Emerging Trends
5.1 DNA Vaccines: Gaining Popularity
5.2 M&As in Vaccine Market
5.3 Vaccine Delivery Advancements
6. Pediatric Vaccines
6.1 Pneumococcal
6.2 Polio
6.3 Varicella
6.4 Meningococcal
6.5 Rotavirus
6.6 DTP
6.7 Measles, Mumps & Rubella (MMR)
6.8 Tuberculosis
7. Adult/Travel & Therapeutic Vaccines
7.1 Hepatitis B
7.2 Malaria
7.3 Yellow Fever
7.4 Rabies
7.5 Japanese Encephalitis
7.6 Typhoid
7.7 West Nile
7.8 HIV
7.9 Cancer
7.10 Influenza
8. Key Geographical Markets
8.1 US
8.1.1 Market Overview
8.1.2 Key Players
8.1.3 Product Portfolio
8.2 Europe
8.2.1 Market Overview
8.2.2 Key Players
8.2.3 Product Portfolio
8.3 China
8.3.1 Market Overview
8.3.2 Key Players
8.3.3 Product Portfolio
8.4 India
8.4.1 Market Overview
8.4.2 Key Players
8.4.3 Product Portfolio
8.5 Japan
8.5.1 Market Overview
8.5.2 Key Players
8.5.3 Product Portfolio
8.6 Brazil
8.6.1 Market Overview
8.6.2 Key Players
8.6.3 Product Portfolio
9. Restraints in Vaccine Industry
9.1 High R&D Cost
9.2 Lack of Infrastructure for Trials and Manufacturing
9.3 Vaccine Supply
9.4 Ineffective Distribution
10. Competitive Landscape
10.1 Sanofi-Aventis
10.2 Novartis
10.3 GSK
10.4 Pfizer
10.5 Merck & Co.